Georgios Papageorgiou

ORCID: 0000-0002-8370-9802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Bipolar Disorder and Treatment
  • Neuroblastoma Research and Treatments
  • Privacy, Security, and Data Protection
  • Mental Health and Psychiatry
  • PARP inhibition in cancer therapy
  • Social Media and Politics
  • Blood disorders and treatments
  • Focus Groups and Qualitative Methods
  • Peptidase Inhibition and Analysis
  • Aortic Disease and Treatment Approaches
  • Neuroendocrine Tumor Research Advances
  • HER2/EGFR in Cancer Research
  • DNA Repair Mechanisms
  • Glioma Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Lung Cancer Research Studies
  • Treatment of Major Depression
  • Moyamoya disease diagnosis and treatment
  • Multiple Myeloma Research and Treatments
  • Brain Metastases and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer Immunotherapy and Biomarkers
  • Abdominal vascular conditions and treatments
  • Neurological Complications and Syndromes

IASO General Hospital
2023-2025

National and Kapodistrian University of Athens
2006-2023

Metaxa Hospital
2020-2023

Eginition Hospital
2022-2023

Marymount University
2021

Hygeia Hospital
2020

Aristotle University of Thessaloniki
2020

General Hospital of Attica
2020

University of the Aegean
2014-2018

Evangelismos Hospital
2010-2015

Phantosmia belongs to the group of olfactory dysfunctions. It is more commonly described in psychiatric conditions and some cases viral infections, but it has been also rarely cancer patients who develop primary or metastatic central nervous system tumors; early identification this symptom population crucial, as could lead timely diagnosis treatment through a multidisciplinary approach. With current report we present case 60-year-old lady with breast without known preexisting brain...

10.37796/2211-8039.1641 article EN cc-by Biomedicine 2025-02-27

10.3794/johlste.81.183 article EN Journal of Hospitality Leisure Sport & Tourism Education 2009-05-01

10.1057/palgrave.thr.2007.15 article EN Tourism and Hospitality Research 2008-01-01

CNS tumors are one of the most common causes cancer-related death in 15- to 39-year-old age group. The management adolescents and young adults (AYAs) who diagnosed with brain presents unique endocrine, developmental, psychosocial issues. AYAs frequently late, after a prolonged period misdiagnosis. epidemiology, biology, prognosis, overall these differ from those both older younger groups. usually transitional phase their lives, this group carry better prognosis than adults; thus, special...

10.1200/jop.18.00767 article EN JCO Oncology Practice 2020-01-21

Induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) is almost universally complicated by febrile neutropenia(FN). Empirical broad-spectrum antibiotic therapy (EBAT) strategies advocated guidelines result in long periods of therapy. We compared the outcome AML/MDS patients treated with a 3-day versus prolonged (until neutrophil recovery) regimen.This retrospective comparative cohort study AML MDS undergoing remission-induction from 2011 to 2019, comparing...

10.1016/j.eclinm.2021.100855 article EN cc-by EClinicalMedicine 2021-04-25

Abstract Treatment of schizophrenia with antipsychotic drugs is frequently sub-optimal. One reason for this may be heterogeneity between patients schizophrenia. The objectives study were to identify patient, disease and treatment attributes that are important physicians in choosing an drug, empirically subgroups who respond differentially drugs. survey was conducted by structured interview 744 randomly-selected psychiatrists four European countries recruited 3996 Information on 39 variables...

10.1016/s0924-9338(11)71709-6 article EN European Psychiatry 2011-03-01

Poor adherence to antipsychotic treatment is a widespread problem within schizophrenia therapy with serious consequences including increased risks of relapse and rehospitalization. Mounting evidence supports the key roles that nurses play in monitoring patient progress facilitating long-term adherence. The Adherencia Terapéutica en la Esquizofrenia (ADHES) nurses' survey was designed assess opinions on causes management partial/nonadherence medication.A questionnaire-based cross-sectional...

10.1177/2045125315612013 article EN Therapeutic Advances in Psychopharmacology 2015-11-04

Poly-ADP ribose polymerase (PARP) inhibitors are constantly increasing in their indications for use as anti-cancer treatment various neoplasms, the majority of which linked with BRCA deficiency. Preclinical data support investigation PARP other neoplasms exhibiting “BRCAness” or homologous recombination deficiency (HRD) monotherapy well combination chemotherapy. With current report we present case a heavily pretreated 55-year-old male patient diagnosed stage IV ATM-deficient CRC, who was...

10.3389/fonc.2021.788809 article EN cc-by Frontiers in Oncology 2021-12-22

This article addresses points to consider when switching patients the second-generation antipsychotic (SGA), ziprasidone, in everyday clinical practice: 1) pharmacologic properties of pre-switch and ziprasidone; 2) switch dosing strategies ensure maintenance or attainment efficacy; 3) recognition management possible rebound effects medication discontinuation; 4) potential side 5) education support for patients/caregivers concerning correct ziprasidone administration.A Medline search (up July...

10.3810/pgm.2011.01.2255 article EN Postgraduate Medicine 2011-01-01

Monoclonal antibodies against programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1) are the main representatives in field of immunotherapy their indications constantly increasing medical oncology hematology during last decade. They associated with long-lasting responses an acceptable toxicity profile, although they may infrequently cause life-threatening complications requiring prolonged hospitalization or urgent interventions. With current report, we present case a 75-year-old...

10.1097/cad.0000000000001247 article EN Anti-Cancer Drugs 2021-09-17

Trastuzumab emtansine (T-DM1) is a human epidermal growth factor receptor 2 (Her2) – targeted antibody-drug conjugate that approved for patients previously treated with trastuzumab and taxane Her2-positive advanced breast cancer those who have progressed within 6 months of completion adjuvant chemotherapy, as well residual invasive disease after the chemotherapy. Peripheral neuropathy common adverse event; however, ocular events also been described. With current report we present case...

10.1097/cad.0000000000001117 article EN Anti-Cancer Drugs 2021-07-04

Glioblastoma multiforme is a malignant central nervous system (CNS) disease with dismal prognosis. Current treatment modalities only offer modest activity and usually of short duration, so there an urgent need for the conduct clinical trials exploring new options modalities. The vincristine-irinotecan-temozolomide bevacizumab (VITb) regimen option special interest, as it has produced encouraging results in young patients various relapsed/refractory childhood adolescence solid tumors,...

10.1097/cad.0000000000001021 article EN Anti-Cancer Drugs 2020-11-20

Forty-three schizophrenic patients participating in this study were serotyped for human leukocyte antigens (HLA-A, -B, -C, -DR, -DQ antigens). Thirty-six of them hospitalised two state mental hospitals and 7 our general hospital, psychiatric unit. The from unit typed HLA before commencing clozapine treatment whereas the after treatment. Three out 43 developed agranulocytosis. One had a combination both 'high-risk' haplotypes (HLA-B16(38,39), DR4, DQ3 HLA-DR2, DQ1), another DQ1, last totally...

10.1159/000119351 article EN Neuropsychobiology 1997-01-01

10.1016/j.bjps.2007.08.022 article EN Journal of Plastic Reconstructive & Aesthetic Surgery 2008-02-22
Coming Soon ...